当前位置: X-MOL 学术Lancet Infect Dis › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Bulevirtide and tenofovir combination therapy for hepatitis D virus infection: longer treatment and more diverse trial populations are needed
The Lancet Infectious Diseases ( IF 56.3 ) Pub Date : 2022-09-13 , DOI: 10.1016/s1473-3099(22)00412-1
Takanori Ito 1 , Mindie H Nguyen 2
Affiliation  

Abstract not available

中文翻译:

Bulevirtide 和替诺福韦联合治疗丁型肝炎病毒感染:需要更长时间的治疗和更多样化的试验人群

摘要不可用
更新日期:2022-09-13
down
wechat
bug